However, there were interactions between estrogens and plasma AD biomarkers on volume of several brain regions; both E1 and E2 had a stronger positive association with regional brain volumes among women with worse AD biomarkers as measured by lower Aβ42/40 or Aβ42/p-tau 181 ratios. The gene discussed is MAPT; the disease is Alzheimer disease.